Cited by 391T-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 278 of the 278 references it cites were found in a registry or an index.

Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family

Open access

Bour‐Jordan, Hélène, Esensten, Jonathan H., Martinez‐Llordella, Marc, Penaranda, Cristina, Stumpf, Melanie, Bluestone, Jeffrey A.·2011·Immunological Reviews

DOI 10.1111/j.1600-065x.2011.01011.xPMC PMC3077803

Open this paper in CoChat — free account

Abstract

Summary: Positive and negative costimulation by members of the CD28 family is critical for the development of productive immune responses against foreign pathogens and their proper termination to prevent inflammation‐induced tissue damage. In addition, costimulatory signals are critical for the establishment and maintenance of peripheral tolerance. This paradigm has been established in many animal models and has led to the development of immunotherapies targeting costimulation pathways for the treatment of cancer, autoimmune disease, and allograft rejection. During the last decade, the complexity of the biology of costimulatory pathways has greatly increased due to the realization that costimulation does not affect only effector T cells but also influences regulatory T cells and antigen‐presenting cells. Thus, costimulation controls T‐cell tolerance through both intrinsic and extrinsic pathways. In this review, we discuss the influence of costimulation on intrinsic and extrinsic pathways of peripheral tolerance, with emphasis on members of the CD28 family, CD28, cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4), and programmed death‐1 (PD‐1), as well as the downstream cytokine interleukin‐1 (IL‐2).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1600-065x.2011.01011.x

Cites

278 of 278 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 201–278 of 278

CD28 Function: A Balance of Costimulatory and Regulatory Signals
Bour-Jordan, H., & Bluestone, J. A. (2002) · Journal of Clinical Immunology · doi:10.1023/a:1014256417651 · Cited by 133
Self-citation
Apoptosis and the homeostatic control of immune responses
Hildeman, D. A., Jørgensen, T. N., Kappler, J. W., & Marrack, P. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.05.005 · Cited by 131
Negative Regulation of T Cell Receptor–Lipid Raft Interaction by Cytotoxic T Lymphocyte–associated Antigen 4
Chikuma, S., Imboden, J. B., & Bluestone, J. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021646 · Cited by 129
Self-citation
CTLA-4 Suppresses Proximal TCR Signaling in Resting Human CD4+ T Cells by Inhibiting ZAP-70 Tyr319 Phosphorylation: A Potential Role for Tyrosine Phosphatases
Guntermann, C., & Alexander, D. R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4420 · Cited by 127
Low-strength T-cell activation promotes Th17 responses
Purvis, H. A., Stoop, J. N., Mann, J., Woods Jon, S., Kozijn, A. E., Hambleton, S., Robinson, J. H., Isaacs, J. D., Anderson, A. E., & Hilkens, C. M. U. (2010) · Blood · doi:10.1182/blood-2010-03-272153 · Cited by 126
Control of Memory CD4 T Cell Recall by the CD28/B7 Costimulatory Pathway
Ndejembi, M. P., Teijaro, J. R., Patke, D. S., Bingaman, A. W., Chandok, M. R., Azimzadeh, A. M., Nadler, S. G., & Färber, D. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7698 · Cited by 124
Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA‐4 expression
Birebent, B., Lorho, R., Lechartier, H., de Guibert, S., Alizadeh, M., Vu, N., Beauplet, A., Robillard, N., & Sémana, G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324632 · Cited by 123
Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes.
Wicker, L. S., Todd, J. A., Prins, J., Podolin, P. L., Renjilian, R. J., & Peterson, L. B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1705 · Cited by 122
CTLA-4 regulates cell cycle progression during a primary immune response
Greenwald, R. J., Oosterwegel, M. A., van der Woude, D., Kubal, A., Mandelbrot, D. A., Boussiotis, V. A., & Sharpe, A. H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2 · Cited by 120
CTLA-4–Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic Mice
Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Belladonna, M. L., Fioretti, M. C., SERREZE, D. V., Grohmann, U., & Puccetti, P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040942 · Cited by 120
Cutting Edge: CTLA-4–B7 Interaction Suppresses Th17 Cell Differentiation
Ying, H., Yang, L., Qiao, G., Li, Z., Zhang, L., Yin, F., Xie, D., & Zhang, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903369 · Cited by 115
Dynamic regulation of T‐cell costimulation through TCR–CD28 microclusters
Yokosuka, T., & Saito, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00779.x · Cited by 109
CD28 Co-Stimulation Down Regulates Th17 Development
Bouguermouh, S., Fortin, G., Baba, N., Rubio, M., & Sarfati, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005087 · Cited by 104
AIRE in the thymus and beyond
Gardner, J. M., Fletcher, A. L., Anderson, M. S., & Turley, S. J. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.08.007 · Cited by 103
Increased Expression of Soluble Cytotoxic T‐Lymphocyte‐Associated Antigen‐4 Molecule in Patients with Systemic Lupus Erythematosus
Liu, M. ‐., Wang, C., Chen, P., & Fung, L. ‐. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01232.x · Cited by 102
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
Lühder, F., Chambers, C. A., Allison, J. P., Benoist, C. O., & Mathis, D. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200348397 · Cited by 102
Normal Regulatory α/β T Cells Effectively Eliminate Abnormally Activated T Cells Lacking the Interleukin 2 Receptor β in Vivo
Suzuki, H., Zhou, Y., Kato, M., Mak, T. W., & Nakashima, I. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1561 · Cited by 102
Pillars Article: CTLA-4 Can Function as a Negative Regulator of T Cell Activation. Immunity. 1994. 1: 405–413
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (2011) · The Journal of Immunology · doi:10.1093/ji/187.7.3466 · Cited by 100
Self-citation
Inhibition of CTLA-4 Function by the Regulatory Subunit of Serine/Threonine Phosphatase 2A
Baroja, M. L., Vijayakrishnan, L., Bettelli, E., Darlington, P. J., Chau, T. A., Ling, V., Collins, M. A., Carreno, B. M., Madrenas, J., & Kuchroo, V. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5070 · Cited by 97
T Cell Effector Function and Anergy Avoidance Are Quantitatively Linked to Cell Division
Wells, A. D., Walsh, M. C., Sankaran, D., & Turka, L. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2432 · Cited by 96
CTLA-4 regulates the requirement for cytokine-induced signals in TH2 lineage commitment
Bour-Jordan, H., Grogan, J. L., Tang, Q., Auger, J., Locksley, R. M., & Bluestone, J. A. (2003) · Nature Immunology · doi:10.1038/ni884 · Cited by 96
Self-citation
Activation-Induced Inhibition of Interleukin 6–Mediated T Cell Survival and Signal Transducer and Activator of Transcription 1 Signaling
Teague, T. K., Schaefer, B. C., Hildeman, D. A., Bender, J., Mitchell, T., Kappler, J. W., & Marrack, P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.915 · Cited by 96
IL-2 Induces a Competitive Survival Advantage in T Lymphocytes
Dooms, H., Kahn, E. C., Knoechel, B., & Abbas, A. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5973 · Cited by 96
CTLA-4 Activation of Phosphatidylinositol 3-Kinase (PI 3-K) and Protein Kinase B (PKB/AKT) Sustains T-Cell Anergy without Cell Death
Schneider, H., Valk, E., Leung, R., & Rudd, C. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003842 · Cited by 94
Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling
Zhang, X., Schwartz, J.-C. D., Almo, S. C., & Nathenson, S. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252771499 · Cited by 93
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance
Li, L., Iwamoto, Y., Berezovskaya, A., & Boussiotis, V. A. (2006) · Nature Immunology · doi:10.1038/ni1398 · Cited by 90
The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28
Marengère, L. E. M., Okkenhaug, K., Clavreul, A., Couez, D., Gibson, S. B., Mills, G. B., Mak, T. W., & Rottapel, R. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3220 · Cited by 88
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-κB subunits on IL-8 and Bcl-xL gene promoters
Marinari, B., Costanzo, A., Marzano, V., Piccolella, E., & Tuosto, L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308688101 · Cited by 84
Targeted Knock-In Mice Expressing Mutations of CD28 Reveal an Essential Pathway for Costimulation
Dodson, L. F., Boomer, J. S., Deppong, C. M., Shah, D. D., Sim, J. E., Bricker, T. L., Russell, J. H., & Green, J. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01869-08 · Cited by 84
Role of B7 in T Cell Tolerance
Lohr, J. G., Knoechel, B., Kahn, E. C., & Abbas, A. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5028 · Cited by 83
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity. 1995. 3: 87-98.
Boise, L., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (2010) · PubMed · Cited by 83
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
Arreaza, G., Cameron, M. J., Jaramillo, A., Gill, B. M., Hardy, D., Laupland, K. B., Rapoport, M. J., Zucker, P., Chakrabarti, S., Chensue, S. W., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119762 · Cited by 82
Defective Activation of Protein Kinase C and Ras-ERK Pathways Limits IL-2 Production and Proliferation by CD4+CD25+ Regulatory T Cells
Hickman, S. P., Yang, J., Thomas, R. M., Wells, A. D., & Turka, L. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2186 · Cited by 79
B7-Independent Inhibition of T Cells by CTLA-4
Chikuma, S., Abbas, A. K., & Bluestone, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.177 · Cited by 79
Self-citation
Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK
King, P. D., Sadra, A., Teng, J. M. C., Xiao-Rong, L., Han, A. S., Selvakumar, A., August, A., & Dupont, B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.580 · Cited by 78
CTLA-4 and Tolerance: The Biochemical Point of View
Chikuma, S., & Bluestone, J. A. (2003) · Immunologic Research · doi:10.1385/ir:28:3:241 · Cited by 78
Self-citation
Tyrosine Phosphatase SHP-2 Binding to CTLA-4: Absence of Direct YVKM/YFIP Motif Recognition
Schneider, H., & Rudd, C. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2234 · Cited by 78
Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2)
Morton, P. A., Fu, X. T., Stewart, J. A., Giacoletto, K. S., White, S. L., Leysath, C. E., Evans, R. J., Shieh, J. J., & Karr, R. W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1047 · Cited by 74
Genetic Evidence That the Differential Expression of the Ligand-Independent Isoform of CTLA-4 Is the Molecular Basis of the Idd5.1 Type 1 Diabetes Region in Nonobese Diabetic Mice
Araki, M., Chung, D., Liu, S. M., Rainbow, D. B., Chamberlain, G., Garner, V. E. S., Hunter, K. M. D., Vijayakrishnan, L., Peterson, L. B., Oukka, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802610 · Cited by 74
T Cell Costimulation: A Rational Target in the Therapeutic Armamentarium for Autoimmune Diseases and Transplantation
Vincenti, F. G., & Luggen, M. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.080205.154004 · Cited by 74
Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)
Griffin, M. D., Hong, D. K., Holman, P. O., Lee, K., Whitters, M. J., O’Herrin, S. M., Fallarino, F., Collins, M. A., Segal, D. M., Gajewski, T. F., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4433 · Cited by 73
Self-citation
CD25+CD4+ regulatory T cells exert in vitro suppressive activity independent of CTLA-4
Kataoka, H. (2005) · International Immunology · doi:10.1093/intimm/dxh221 · Cited by 73
CD28 Regulates the Translation of Bcl-xL via the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Pathway
Wu, L., Rose, J. L., Chen, L., Neale, C., Mak, T. W., Okkenhaug, K., Wange, R. L., & Rottapel, R. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.180 · Cited by 68
Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist
Fife, B. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27856 · Cited by 68
New Reagents on the Horizon for Immune Tolerance
Clair, E. W. S., Turka, L. A., Saxon, A., Matthews, J. B., Sayegh, M. H., Eisenbarth, G. S., & Bluestone, J. A. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145449 · Cited by 63
Self-citation
GRID: A Novel Grb-2-Related Adapter Protein That Interacts with the Activated T Cell Costimulatory Receptor CD28
Ellis, J. H., Ashman, C., Burden, M. N., Kilpatrick, K. E., Morse, M. A., & Hamblin, P. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5805 · Cited by 60
CD28 stimulation triggers NF- B activation through the CARMA1-PKC -Grb2/Gads axis
Takeda, K., Harada, Y., Watanabe, R., Inutake, Y., Ogawa, S., Onuki, K., Kagaya, S., Tanabe, K., Kishimoto, H., & Abe, R. (2008) · International Immunology · doi:10.1093/intimm/dxn108 · Cited by 58
NF-κB-Inducing Kinase Is Involved in the Activation of the CD28 Responsive Element through Phosphorylation of c-Rel and Regulation of Its Transactivating Activity
Sánchez-Valdepeñas, C., Martín, Á. G., Ramakrishnan, P., Wallach, D., & Fresno, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4666 · Cited by 57
Effective Proliferation of Human Regulatory T Cells Requires a Strong Costimulatory CD28 Signal That Cannot Be Substituted by IL-2
Hombach, A. A., Kofler, D. M., Hombach, A., Rappl, G., & Abken, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7924 · Cited by 55
Striking Dichotomy of PD-L1 and PD-L2 Pathways in Regulating Alloreactive CD4+ and CD8+ T Cells In Vivo
Habicht, A., Kewalaramani, R., Vu, D. M., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01999.x · Cited by 55
Re-establishing Peripheral Tolerance in the Absence of CTLA-4: Complementation by Wild-Type T Cells Points to an Indirect Role for CTLA-4
Tivol, E. A., & Gorski, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1852 · Cited by 53
Opposing Roles for the Cyclin-Dependent Kinase Inhibitor p27 kip1 in the Control of CD4+ T Cell Proliferation and Effector Function
Rowell, E. A., Walsh, M. C., & Wells, A. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3359 · Cited by 53
Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis
Reiman, R. M., Gerard, C. J., Campbell, I. L., & Barnum, S. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4 · Cited by 53
Cloning of the APECED gene provides new insight into human autoimmunity
Aaltonen, J., & Björses, P. (1999) · Annals of Medicine · doi:10.3109/07853899708998786 · Cited by 52
The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation: Importance of Two Widely Separated IL-2 Response Elements
Kim, H., Kelly, J. A., & Leonard, W. J. (2001) · Cited by 48
Enhanced NFATc1 Nuclear Occupancy Causes T Cell Activation Independent of CD28 Costimulation
Pan, M., Winslow, M. M., Chen, L., Kuo, A., Felsher, D. W., & Crabtree, G. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4315 · Cited by 47
Cutting Edge: Targeted Ligation of CTLA-4 In Vivo by Membrane-Bound Anti-CTLA-4 Antibody Prevents Rejection of Allogeneic Cells
Hwang, K. W., Sweatt, W. B., Brown, I. E., Blank, C. U., Gajewski, T. F., Bluestone, J. A., & Alegre, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.633 · Cited by 44
Self-citation
CTLA-4 and CD28: similar proteins, neighbouring genes.
Balzano, C., Buonavista, N., Rouvier, É., & Golstein, P. (1992) · PubMed · Cited by 40
Novel mechanism of signaling by CD28
Bjørgo, E., & Taskén, K. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.01.007 · Cited by 35
Regulation of T Cell Activation and Tolerance by Phospholipase Cγ-1-Dependent Integrin Avidity Modulation
Wells, A. D., Liu, Q., Hondowicz, B. D., Zhang, J., Turka, L. A., & Freedman, B. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4127 · Cited by 34
Two pathways of costimulation through CD28
Miller, J., Baker, C. M., Cook, K. D., Graf, B. A., Sánchez-Lockhart, M., Sharp, K., Wang, X., Yang, B. C., & Yoshida, T. (2009) · Immunologic Research · doi:10.1007/s12026-009-8097-6 · Cited by 34
Expression of CTLA‐4 and FOXP3 in cis protects from lethal lymphoproliferative disease
Chikuma, S., & Bluestone, J. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737159 · Cited by 32
Self-citation
Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis
de Jong, Y. P. (2004) · International Immunology · doi:10.1093/intimm/dxh019 · Cited by 32
The role of positive costimulatory molecules in transplantation and tolerance
Agarwal, A., & Newell, K. A. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328306115b · Cited by 31
The Cyclin-Dependent Kinase Inhibitor p27kip1 Is Required for Transplantation Tolerance Induced by Costimulatory Blockade
Rowell, E. A., Wang, L., Hancock, W. W., & Wells, A. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5169 · Cited by 31
Paradoxical Functions of B7: CD28 Costimulation in a MHC Class II-Mismatched Cardiac Transplant Model
Yang, J., Riella, L. V., Boenisch, O., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02839.x · Cited by 30
CD28 Signaling in T Regulatory Precursors Requires p56lck and Rafts Integrity to Stabilize the Foxp3 Message
Nazarov–Stoica, C., Surls, J., Bona, C. A., Casares, S. A., & Brumeanu, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.102 · Cited by 29
Maintenance of Peripheral Tolerance through Controlled Tissue Homing of Antigen-Specific T Cells in K14-mOVA Mice
Bianchi, T., Pincus, L. B., Wurbel, M., Rich, B. E., Kupper, T. S., Fuhlbrigge, R. C., & Boes, M. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803628 · Cited by 28
Development and applications of surface-linked single chain antibodies against T-cell antigens
Griffin, M. D., Holman, P. O., Tang, Q., Ashourian, N., Korthäuer, U., Kranz, D. M., & Bluestone, J. A. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00344-6 · Cited by 28
Self-citation
The Role of TCR Specificity in Naturally Arising CD25+ CD4+ Regulatory T Cell Biology
Hsieh, C., & Rudensky, A. Y. (2005) · Springer eBooks · doi:10.1007/3-540-27702-1_2 · Cited by 26
Cutting Edge: Two Distinct Mechanisms Lead to Impaired T Cell Homeostasis in Janus Kinase 3- and CTLA-4-Deficient Mice
Gozalo-Sanmillan, S., McNally, J. M., Lin, M. Y., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.727 · Cited by 24
Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo
Yi, L. (2004) · International Immunology · doi:10.1093/intimm/dxh055 · Cited by 24
CTLA-4 (CD152) and its involvement in autoimmune disease
Holmberg, D., Cilio, C., Lundholm, M., & Motta, V. N. (2005) · Autoimmunity · doi:10.1080/08916930500050210 · Cited by 20
Regulating Treg Cells at Sites of Inflammation
Lazarski, C. A., Hughson, A. L., Sojka, D. K., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.012 · Cited by 9
The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2
Eugster (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1521-4141(199807)28:07 · Cited by 2
Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)
(2002) · doi:10.1002/1521-4141(200208)32:8
Untitled work
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Untitled work
(1999) · doi:10.1002/(sici)1521-4141(199903)29:03

Flagged first, then by citations

Sorted by citations

CTLA-4: a moving target in immunotherapy
Rowshanravan, B., Halliday, N., & Sansom, D. M. (2018) · Blood · doi:10.1182/blood-2017-06-741033 · Cited by 1,233
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
Self-citation
Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors
Stamatouli, A. M., Quandt, Z., Perdigoto, A. L., Clark, P. L., Kluger, H., Weiss, S. A., Gettinger, S., Sznol, M., Young, A., Rushakoff, R., et al. (2018) · Diabetes · doi:10.2337/dbi18-0002 · Cited by 590
Self-citation
The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology
Huff, W. X., Kwon, J. H., Henriquez, M., Fetcko, K., & Dey, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112810 · Cited by 217
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Mondal, A. M., Horikawa, I., Pine, S. R., Fujita, K., Morgan, K. M., Vera, E., Mazur, S. J., Appella, E., Vojtesek, B., Blasco, M. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70355 · Cited by 164

See all 391

Authors: Bour‐Jordan, H., Esensten, J. H., Martinez‐Llordella, M., Penaranda, C., Stumpf, M., & Bluestone, J. A.
Affiliations: University of California, San Francisco (US)
Corresponding author: Bluestone, Jeffrey A.
ORCID: Esensten, Jonathan H.
Bluestone, Jeffrey A.
Venue: Immunological Reviews
Publisher: Wiley
Published: 2011-04-13
Volume: 241
Issue: 1
Pages: 180-205
ISSN: 0105-2896 (ISSN-L)
1600-065X
DOI: 10.1111/j.1600-065x.2011.01011.x
PMC: PMC3077803
OpenAlex: W1907829837
Cited by: 391
References: 278
Citations by year: 2026: 6 · 2025: 13 · 2024: 15 · 2023: 12 · 2022: 13 · 2021: 26 · 2020: 17 · 2019: 23 · 2018: 20 · 2017: 26 · 2016: 34 · 2015: 47 · 2014: 36 · 2013: 49 · 2012: 40
FWCI: 4.00
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Immunological Reviews (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: National Institute of Allergy and Infectious Diseases (P01AI035294, R01AI050834, R37AI046643)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK063720)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: peripheral T cell tolerance, CD28/B7 costimulation, CD28, CTLA-4, PD-1, interleukin-2, regulatory T cells, antigen-presenting cells, costimulatory pathways
MeSH terms: Animals, Antigen-Presenting Cells, Autoimmune Diseases, Graft Rejection, Humans, Immune Tolerance, Immunotherapy, Neoplasms, Antigens, CD, T-Lymphocyte Subsets, CD28 Antigens, B7-1 Antigen, Receptor Cross-Talk, T-Lymphocytes, Regulatory, Apoptosis Regulatory Proteins, CTLA-4 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks